Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens

S George; M Heinrich; P Chi; A Razak; M von Mehren; M Gordon; K.N Ganjoo; N Somaiah; J.C Trent; J Rodon Ahnert; J Wolf; R Ruiz-Soto; O Rosen; F Janku

doi:10.1093/annonc/mdy299.002

Back

Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens

Journal article

Open access

Peer reviewed

Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens

S George, M Heinrich, P Chi, A Razak, M von Mehren, M Gordon, K.N Ganjoo, N Somaiah, J.C Trent, J Rodon Ahnert, …

Annals of oncology, Vol.29, pp.viii576-viii577

2018-10

DOI: https://doi.org/10.1093/annonc/mdy299.002

PMID: 32137524

Files and links (1)

url

https://doi.org/10.1093/annonc/mdy299.002View

Published (Version of record) Open

Metrics

7 Record Views

Details

Title: Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens
Creators: S George - Medical Oncology, Dana Faber Cancer Institute, Boston, MA, USA
M Heinrich - Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
P Chi - Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
A Razak - Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
M von Mehren - Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
M Gordon - Medical Oncology, HonorHealth Virginia G Piper Cancer Care Network, Scottsdale, AZ, USA
K.N Ganjoo - Oncology, Stanford Cancer Institute, Stanford, CA, USA
N Somaiah - Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA
J.C Trent - Medical Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA
J Rodon Ahnert - Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA
J Wolf - Biostatistician, Wolf Consulting Biostatistician, Denver, CO, USA
R Ruiz-Soto - Clinical Research, Deciphera Pharmaceuticals, Waltham, MA, USA
O Rosen - Clinical, Deciphera Pharmaceuticals, New York, MA, USA
F Janku - Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, TX, USA
Publication Details: Annals of oncology, Vol.29, pp.viii576-viii577
Publisher: Elsevier Ltd
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 32137524
Record Identifier: 991031598307802976